COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS – Regeneron Pharmaceuticals, Inc. Transaction History
COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS portfolio value:
$10.80M
portfolio value
COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -0.32% | -50 shares | 1.50M | $688.87 | 15.67K |
| Q2 2022 | share | Increase | +10.15% | 1.45K shares | -675K | $591.13 | 15.72K |
| Q1 2022 | share | Increase | +7.60% | 1.00K shares | 1.59M | $698.42 | 14.27K |
| Q4 2021 | share | Increase | +0.74% | 98 shares | 409K | $642.51 | 13.27K |
| Q3 2021 | share | Increase | +0.42% | 55 shares | 645K | $605.18 | 13.17K |
| Q2 2021 | share | Decrease | -0.38% | -50 shares | 1.09M | $558.54 | 13.11K |
| Q1 2021 | share | Increase | +0.50% | 65 shares | -100K | $473.14 | 13.16K |
| Q4 2020 | share | Increase | +35.27% | 3.41K shares | 908K | $483.11 | 13.10K |
| Q3 2020 | share | Increase | +67.93% | 3.91K shares | 1.82M | $559.78 | 9.68K |
| Q2 2020 | share | Increase | +13.03% | 665 shares | 1.10M | $623.65 | 5.76K |
| Q1 2020 | share | Decrease | -0.80% | -41 shares | 561K | $488.29 | 5.10K |
| Q4 2019 | share | Increase | +0.47% | 24 shares | 511K | $375.48 | 5.14K |
| Q3 2019 | share | Increase | +10.89% | 503 shares | -25K | $277.4 | 5.12K |
| Q2 2019 | share | Increase | +0.76% | 35 shares | -436K | $313 | 4.61K |
| Q1 2019 | share | Increase | +8.22% | 348 shares | 300K | $410.62 | 4.58K |
| Q4 2018 | share | Decrease | -33.42% | -2.12K shares | -988K | $373.5 | 4.23K |
| Q3 2018 | share | Decrease | -21.46% | -1.73K shares | -224K | $404.04 | 6.35K |
| Q2 2018 | share | Increase | +17.16% | 1.18K shares | 413K | $344.99 | 8.09K |
| Q1 2018 | share | Increase | +0.28% | 19 shares | -211K | $344.36 | 6.91K |
| Q4 2017 | share | Increase | +10.29% | 643 shares | -203K | $375.96 | 6.89K |
| Q3 2017 | share | Increase | +10.37% | 587 shares | 14K | $447.12 | 6.24K |
| Q2 2017 | share | Increase | +0.35% | 20 shares | 594K | $491.14 | 5.66K |
| Q1 2017 | share | Increase | +30.16% | 1.30K shares | 595K | $387.51 | 5.64K |
| Q4 2016 | share | Increase | +0.56% | 24 shares | -142K | $367.09 | 4.33K |
| Q3 2016 | share | Decrease | -30.98% | -1.93K shares | -448K | $402.02 | 4.31K |
| Q2 2016 | share | Increase | +7.78% | 451 shares | 93K | $349.23 | 6.24K |
| Q1 2016 | share | Increase | +14.24% | 722 shares | -665K | $360.44 | 5.79K |